Literature DB >> 15201193

Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat.

Hannah Pellkofer1, Anna S Schubart, Romana Höftberger, Nadine Schutze, Maria Pagany, Martina Schüller, Hans Lassmann, Reinhard Hohlfeld, Raymond Voltz, Christopher Linington.   

Abstract

Antibodies directed against onconeuronal antigens provide a specific diagnostic marker for paraneoplastic neurological syndromes (PNS) and suggest that these autoantigens are targeted during disease pathogenesis. However, so far attempts to generate autoimmune models of PNS have been unsuccessful. Here we show that the adoptive transfer of T-cells specific for the autologous onconeuronal antigen Pnma1 cause encephalomyelitis in the Dark Agouti (DA) rat. The sequence of rat Ma1 (rPnma1) was determined by RT-PCR using primers for human PNMA1, followed by 5' and 3' genome walking. Rat Pnma1 is 93.8% identical to human PNMA1 at the amino acid level. Rat Pnma1 was cloned into the expression vector pQE60, and recombinant protein purified by metal chelate chromatography. Female DA rats were immunized with recombinant rPnma1 and rPnma1-specific CD4+ T-helper 1 (Th1) T-cell lines generated from the draining lymph nodes 10 days post-immunization. Freshly activated T-cell blasts were transferred into naive female DA rats, which were killed up to 9 days later. Proliferation assays demonstrated that the CD4+ Th1 T-cells were highly specific for rPnma1. After T-cell transfer the recipients developed a perivascular inflammatory response involving CNS regions affected in human disease. Anti-Pnma1 antibodies were induced by protein immunization, but this was associated with minimal CNS pathology. The induction of an inflammatory response in the CNS following the adoptive transfer of rat Pnma1-specific T-cells demonstrates for the first time that a paraneoplastic autoantigen can initiate a pathogenic effector T-cell response. This animal model strongly supports the hypothesis that the pathogenesis of paraneoplastic CNS neurological syndromes in man involves an autoimmune T-cell component.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15201193     DOI: 10.1093/brain/awh205

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  23 in total

Review 1.  Paraneoplastic syndromes of the CNS.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Lancet Neurol       Date:  2008-04       Impact factor: 44.182

Review 2.  Neuropsychological symptoms in paraneoplastic disorders.

Authors:  Raymond Voltz
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

Review 3.  Cortical, subcortical and spinal alterations in neuroimmunological diseases.

Authors:  Hans Lassmann
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

4.  [Therapeutic options for autoimmune encephalomyelitis].

Authors:  N Borisow; H Prüss; F Paul
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

Review 5.  Autoimmune epilepsies.

Authors:  Christian G Bien; Jan Bauer
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

6.  CD4+ and CD8+ T cells are both needed to induce paraneoplastic neurological disease in a mouse model.

Authors:  Christina Gebauer; Béatrice Pignolet; Lidia Yshii; Emilie Mauré; Jan Bauer; Roland Liblau
Journal:  Oncoimmunology       Date:  2016-12-09       Impact factor: 8.110

Review 7.  Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.

Authors:  Ronnyson Susano Grativvol; Wagner Cid Palmeira Cavalcante; Luiz Henrique Martins Castro; Ricardo Nitrini; Mateus Mistieri Simabukuro
Journal:  Curr Oncol Rep       Date:  2018-11-10       Impact factor: 5.075

Review 8.  Intravenous immunoglobulin therapy in paraneoplastic neurological syndromes.

Authors:  Raymond Voltz
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

Review 9.  Neuronal autoantigens--pathogenesis, associated disorders and antibody testing.

Authors:  Eric Lancaster; Josep Dalmau
Journal:  Nat Rev Neurol       Date:  2012-06-19       Impact factor: 42.937

10.  Models of autoimmune demyelination in the central nervous system: on the way to translational medicine.

Authors:  Ralf A Linker; De-Hyung Lee
Journal:  Exp Transl Stroke Med       Date:  2009-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.